Skip to content

GREENWICH LIFESCIENCES, INC.: 10-Q filed 2022-08-15

What GREENWICH LIFESCIENCES, INC. reported in its quarterly report filed 2022-08-15 (fiscal Q2 2022): 21 published measures, 57 facts as tagged in accession 0001493152-22-022956.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-15
Fiscal period
fiscal Q2 2022
Accession
0001493152-22-022956 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GREENWICH LIFESCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-3017,198,699USD
At 2021-12-3127,216,884USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-30229,134USD
At 2021-12-31385,172USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-3016,969,565USD
At 2022-03-3119,513,640USD
At 2021-12-3126,831,712USD
At 2021-06-3029,162,459USD
At 2021-03-3129,747,153USD
At 2020-12-3127,631,110USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-06-3017,187,890USD
At 2021-12-3127,204,269USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-746,073USD91
2022-01-01 to 2022-06-30-2,715,701USD181
2022-01-01 to 2022-03-31-1,969,628USD90
2021-04-01 to 2021-06-30-749,745USD91
2021-01-01 to 2021-06-30-1,346,753USD181
2021-01-01 to 2021-03-31-597,008USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-2,480,163USD181
2021-01-01 to 2021-06-30-1,132,589USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-7,536,216USD181
2021-01-01 to 2021-06-302,272,846USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-36,363,230USD
At 2021-12-31-33,647,529USD

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.06USD/shares91
2022-01-01 to 2022-06-30-0.21USD/shares181
2021-04-01 to 2021-06-30-0.06USD/shares91
2021-01-01 to 2021-06-30-0.11USD/shares181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-06-30389,770USD181
2021-01-01 to 2021-06-30330,102USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-773,307USD91
2022-01-01 to 2022-06-30-2,762,510USD181
2021-04-01 to 2021-06-30-753,445USD91
2021-01-01 to 2021-06-30-1,354,051USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-06-30229,134USD
At 2021-12-31385,172USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-06-3010,809USD
At 2021-12-3112,615USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2022-01-01 to 2022-06-307,536,216USD181

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-30773,307USD91
2022-01-01 to 2022-06-302,762,510USD181
2021-04-01 to 2021-06-30753,445USD91
2021-01-01 to 2021-06-301,354,051USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-04-01 to 2022-06-30633,250USD91
2022-01-01 to 2022-06-302,294,071USD181
2021-04-01 to 2021-06-30556,534USD91
2021-01-01 to 2021-06-30838,511USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-3012,774,809shares
At 2021-12-3113,147,829shares

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-2,715,701USD181
2021-01-01 to 2021-06-30-1,346,753USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30140,057USD91
2022-01-01 to 2022-06-30468,439USD181
2021-04-01 to 2021-06-30196,911USD91
2021-01-01 to 2021-06-30515,540USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2021-01-01 to 2021-06-302,548,000USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-06-30-120,000USD181

Inspect the source

Entity
GREENWICH LIFESCIENCES, INC. / CIK 0001799788
Captured
2026-09-21T17:27:54.821Z
SEC response SHA-256
a617dbe92932ff09e9921f2bebe266085b6d33d46c3d873a6ff42dd23172a3bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001799788.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))